Description
About Jade Biosciences
Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade’s pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an undisclosed antibody candidate, both currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit JadeBiosciences.com and follow the Company on LinkedIn.
Role Overview
Jade Biosciences is seeking an experienced pharmacovigilance leader to serve as the Company's Head of Pharmacovigilance, with accountability for safety strategy, safety science, and PV operations across the portfolio. Reporting to the Chief Medical Officer, this individual will build a fit-for-purpose, inspection-ready PV function designed to scale as JADE101 advances into global Phase 3 and as JADE201 and JADE301 progress through early development.
This is a hands-on, build-oriented role in a lean organization. The successful candidate will operate as both strategist and practitioner — setting safety governance and signal management frameworks while personally overseeing outsourced PV vendors, authoring and reviewing key safety deliverables, and partnering closely with Clinical Development, Regulatory Affairs, Clinical Operations, Biometrics, and Quality. The role may be filled at the Senior Director or Executive Director level depending on experience and scope.
Key Responsibilities
Regulatory Reporting & Safety Documents
- Ensure timely, compliant expedited and periodic reporting (SUSARs, IND safety reports, DSURs) to FDA, EMA, and other health authorities.
- Author or provide senior review of safety content for protocols, Investigator's Brochures, informed consent forms, clinical study reports, and health authority responses.
- Support global expansion, including safety requirements associated with Japanese and Chinese regulatory interactions and multi-region Phase 3 execution.
PV Operations & Vendor Oversight
- Provide strategic and day-to-day oversight of outsourced PV service providers, including safety database management, case processing, reconciliation, literature screening, and submissions.
- Own vendor performance management, KPIs, and quality metrics; manage the PV budget and resourcing model.
- Negotiate and implement safety data exchange agreements (SDEAs/PVAs) with partners, licensors, and CROs.
Quality Systems & Inspection Readiness
- Build and maintain a right-sized PV quality system, including SOPs, work instructions, training curricula, and the PV system master file as applicable.
- Ensure ongoing GVP/GCP compliance and lead PV inspection- and audit-readiness activities with Quality Assurance.
- Identify and close process gaps proactively as the organization transitions from early- to late-stage development.
Leadership & Cross-Functional Partnership
- Partner with Clinical Development, Regulatory, Clinical Operations, Biometrics, Quality, and Program Management as the PV representative on program and development teams.
- Hire, mentor, and develop PV staff and consultants as the function grows; establish scalable processes and a culture of scientific rigor and accountability.
Qualifications
- Bachelor’s with 10-15 years of industry experience with a minimum of 10 years of pharmacovigilance/drug safety experience in the biopharmaceutical industry, with progressive leadership responsibility; Executive Director level requires broader scope and prior head-of-function experience.
- Demonstrated experience as head of PV (or deputy) in a development-stage company, including building fit-for-purpose PV processes and quality systems.
- Deep working knowledge of global PV regulations and guidance (21 CFR, ICH E2A/E2B/E2C/E2D/E2F, EU GVP modules) and of expedited and aggregate reporting requirements.
- Proven track record of PV vendor selection and oversight, including safety database (e.g., Argus) and outsourced case processing operations.
- Experience supporting health authority inspections (FDA and/or EMA) and client/sponsor audits with successful outcomes.
- Excellent scientific judgment, written and verbal communication, and cross-functional collaboration skills.
Preferred
- 10 years of experience with biologics/monoclonal antibodies and with immunology, rheumatology, nephrology, or rare disease programs.
- Experience supporting late-stage global development and BLA/MAA safety deliverables, including risk management plans.
- Familiarity with safety data visualization and analytics tools to support signal detection.
- Experience integrating PV requirements across licensing/partnering relationships.
- Prior experience scaling a PV function from first-in-human through Phase 3 and toward marketing authorization.
Position Location
This is a remote role; periodic travel to team and company events is required.
The anticipated salary range for candidates for this role is $250K - $310K at a Sr Director level and $275K - $330K at the Executive Director level. The final salary offered will depend on several factors, which may include, but not limited to, relevant years of experience, educational background, and geography.
As part of the I-9 verification of authorization to work in the United States, Jade Bioscience participates in E-Verify. To learn more about E-Verify please review this poster.
Jade Biosciences is proud to be an Equal Opportunity employer. All qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected Veteran status, age, or any other characteristic protected by law.
Similar jobs
Est. 250,000 USD
About Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, ta…
Est. 222,500 USD
About Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, ta…
Est. 182,500 USD
About Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, ta…
Est. 135,000 USD
About Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, ta…
Est. 250,000 USD
About Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, ta…
Est. 208,000 USD
About Beeline Medicines: Beeline Medicines is a clinical‑stage biotechnology company focused on developing and delivering category-leading precision therapies to transform the lives of people living with autoimmune and i…
Est. 309,000 USD
Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and co…
Est. 140,000 USD
Umoja Biopharma is an industry-leading biotech with locations in Seattle, WA and Louisville, CO, focused on transforming the treatment of cancer with a novel integrated immunotherapy platform. Our vision is to develop of…
Est. 258,150 USD
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, suppor…
Est. 185,000 USD
Why Join Us? Be a hero for our rare disease patients At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve…
Est. 274,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 274,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 230,000 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 277,000 USD
For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments…
Est. 248,500 USD
Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and co…
Est. 388,500 USD
Join our team in a dynamic hybrid role, offering flexibility to work remotely and from our headquarters in Watertown, MA. COMPANY OVERVIEW: Disc Medicine is a clinical-stage biopharmaceutical company committed to discove…
Est. 274,550 USD
For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments…
Est. 157,500 USD
Arrowhead Pharmaceuticals, Inc. (Nasdaq ARWR) is a commercial stage biopharmaceutical company that develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA…
Est. 320,000 USD
For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments…
Est. 235,000 USD
Company Overview: Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with…
Est. 340,497 USD
Legend Biotech is a global biotechnology company dedicated to treating and, one day, curing life-threatening diseases. Headquartered in Bridgewater, New Jersey, we are advancing the next generation of cell therapy throug…
Est. 337,500 USD
Company: At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases o…
Est. 110,000 USD
Syndax Pharmaceuticals is looking for a Contractor – Senior Drug Safety Specialist At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax Pharmaceutic…
Est. 184,500 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Position Summary: Responsibilities will include but may not be limited to; project specific teleconferences/meetings(i.e. Kick off meetings, internal study specific meetings, client governance meetings) Safety budget rev…
Est. 243,750 USD
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clini…
Est. 282,500 USD
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clini…
Est. 197,500 USD
Arrowhead Pharmaceuticals, Inc. (Nasdaq ARWR) is a commercial stage biopharmaceutical company that develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA…
Est. 250,000 USD
MISSION Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disea…
Est. 298,000 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…